Trials / Completed
CompletedNCT04273672
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cognitive Battery | Participants will be asked to complete a series of cognitive testing (testing of concentration, memory, and other thinking abilities). |
| BEHAVIORAL | Voice, Speech and Language Analysis | Participants will be asked to perform speaking and reading tasks, which will be recorded. Participants will be asked to complete a laptop-based test of language comprehension. |
| BEHAVIORAL | Questionnaires and Clinical Assessments | Participants with Parkinson's disease will complete an examination of their symptoms and questionnaires assessing disease symptoms, mood and activities of daily living. Healthy controls participants will be asked to complete questionnaires on mood. |
| GENETIC | DNA Analysis | Participants will have their blood drawn for DNA analysis. |
Timeline
- Start date
- 2020-01-13
- Primary completion
- 2023-09-01
- Completion
- 2025-02-28
- First posted
- 2020-02-18
- Last updated
- 2025-06-10
- Results posted
- 2025-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04273672. Inclusion in this directory is not an endorsement.